Kent J. Thiry
Chairman and Chief Executive Officer, DaVita Inc., and Chief Executive Officer, DaVita Medical Group
Kent J. Thiry has been our chairman of the Board since June 2015 and from October 1999 until November 2012, and our chief executive officer since October 1999. In October 2014, Mr. Thiry also became chief executive officer of our integrated care business, DMG.
Javier J. Rodriguez
Chief Executive Officer, DaVita Kidney Care
Javier J. Rodriguez became our chief executive officer, DaVita Kidney Care in March 2014. Since joining the Company in 1998, Mr. Rodriguez has served in a number of different capacities. From February 2012 to March 2014, he served as our president. From April 1, 2006 through February 2012, he
Michael D. Staffieri
Chief Operating Officer, DaVita Kidney Care
Michael D. Staffieri became our chief operating officer, DaVita Kidney Care, in March 2014. From July 2011 to February 2014, he served as a senior vice president, Kidney Care. From March 2008 to July 2011, he served as our vice president of operations and new center development. Mr.
Joseph C. Mello
Chief Operating Officer, DaVita Medical Group
Joseph C. Mello became our chief operating officer, DaVita Medical Group, in January 2015. From April 2012 to April 2014, Mr. Mello served on the Board of CapitalSource Inc., a commercial lender, Mr. Mello previously served as our chief operating officer — emeritus from January 2009 to December
President and Chief Executive Officer, DaVita International
Robert Lang became our President and Chief Executive Officer of International in April 2017. Prior to joining DaVita, Mr. Lang was managing director, Bupa International Markets. From 2013-2016, as managing director, Bupa Global, Mr. Lang oversaw the company’s international private medical insurance
Chief Financial Officer, DaVita Inc.
Joel Ackerman became our chief financial officer in March 2017. Prior to joining us, Mr. Ackerman was the chief executive officer of Champions Oncology, Inc., a company engaged in the development of advanced technology solutions and services to personalize the development and use of oncology drugs,
James K. Hilger
Chief Accounting Officer, DaVita Inc.
James K. Hilger serves as our chief accounting officer, a position he has held since April 2010. Prior to April 2010, Mr. Hilger served as our vice president and controller since May 2006, after having served as our vice president, finance beginning in September 2005. Mr.
LeAnne M. Zumwalt
Group Vice President, Purchasing and Public Affairs, DaVita Inc.
LeAnne M. Zumwalt became our group vice president-purchasing and public affairs in July 2011. From January 2000 to July 2011, Ms. Zumwalt served as our vice president in many capacities. From January 2000 to October 2009, she served as our vice president, investor relations while having other
Dr. Allen R. Nissenson
Chief Medical Officer, DaVita Kidney Care
Dr. Allen R. Nissenson became our chief medical officer, DaVita Kidney Care, in March 2014. From August 2008 to March 2014, he served as our chief medical officer. He is an emeritus professor of medicine at the David Geffen School of Medicine at UCLA, where he served as director of the dialysis
Kathleen A. Waters
Chief Legal Officer, DaVita Inc.
Kathleen A. Waters became our chief legal officer in May 2016. Prior to joining the Company, Ms. Waters was senior vice president, general counsel and secretary of Health Net, Inc., a publicly traded managed care organization from April 2015 to March 2016.
James O. Hearty
Chief Compliance Officer, DaVita Inc.
James O. Hearty became our chief compliance officer in March 2018. From September 2015 to March 2018, he served as our senior vice president and chief compliance officer-kidney care, and, prior to that, from February 2012 to August 2015, he served as vice president, associate general counsel.